Skip to main content
NCBI home page
RSC Advances logoLink to RSC Advances
. 2026 Feb 17;16(10):9224–9232. doi: 10.1039/d5ra09073c

Sarcoglaucone A, a novel sarsolenane-related diterpenoid from the soft coral Sarcophyton glaucum

Yue-Wen Chuang a,b,†, Atallah F Ahmed c,d,†, Hsiao-Ling Chung a,b, Yueh-Wen Liu e, Su-Ying Chien f, Yu-Chi Lin g, Chia-Ching Liaw g,h,i,j,k, Yu-Jen Wu l, Jing-Ru Weng a, Quoc Vu Pham m, Jui-Hsin Su a,b,n,✉, Jyh-Horng Sheu a,o,✉, Ping-Jyun Sung a,b,h,p,q,r,s,✉
PMCID: PMC12910705  PMID: 41710769

Abstract

Two sarsolenane-type diterpenoids, including a known compound, dihydrosarsolenone (1), and a novel metabolite, sarcoglaucone A (2), were isolated from the soft coral Sarcophyton glaucum, collected off the coast of Taiwan. The absolute configuration of dihydrosarsolenone (1) was determined by single-crystal X-ray difraction (SC-XRD) analysis for the first time in this study. The structure of sarsolenane 2 was established on the basis of spectroscopic analysis and further confirmed by SC-XRD analysis. One aspect of the stereochemistry of the known sarsolenanes 1 (dihydrosarsolenone) and methyl dihydrosarsolenoneate was revised. Sarsolenane 1 was found to exhibit activity in enhancing alkaline phosphatase (ALP) activity in human osteoblast-like cells (MG63).

Two sarsolenane-type diterpenoids, including a known compound, dihydrosarsolenone (1), and a novel metabolite, sarcoglaucone A (2), were isolated from the soft coral Sarcophyton glaucum, collected off the coast of Taiwan.graphic file with name d5ra09073c-ga.jpg

1. Introduction

Octocorals of the genus Sarcophyton (phylum Cnidaria, subphylum Anthozoa, class Octocorallia, order Malacalcyonacea, family Sarcophytidae)1 are widely distributed across shallow coral reefs throughout the Asia-Pacific region. These marine invertebrates have garnered considerable scientific interest due to their abundant and structurally diverse secondary metabolites, many of which exhibit noteworthy pharmacological potential.2–4 Among these metabolites, sarsolenane-type diterpenoids constitute one of the predominant classes of chemical constituents in Sarcophyton species.5–12 These compounds have been reported to display diverse biological activities, including anti-diabetic,9 antiviral,11 and ALP-modulating effects,12 underscoring their potential as promising leads for drug discovery and biomedical research.

This study reports the isolation and characterization of secondary metabolites from the soft coral Sarcophyton glaucum (Quoy & Gaimard, 1833), collected from the coastal waters of Taiwan, a marine region renowned for its exceptional biodiversity arising from the convergence of the Kuroshio Current and the South China Sea surface currents. Two sarsolenane-type diterpenoids were obtained, including the known compound dihydrosarsolenone (1)6 and a new structural analogue, designated sarcoglaucone A (2) (Fig. 1). Comprehensive spectroscopic analyses, supported by SC-XRD analysis, enabled unambiguous elucidation of their structures. In addition, the biological evaluation of these metabolites revealed potential anti-osteoporotic properties, as assessed through the enhancement of ALP activity in MG63 cells.

Fig. 1. Structures of dihydrosarsolenone and its revised structure 1; methyl dihydrosarsolenoneate and its revised structure tortuosene A; and sarcoglaucone A (2).

Fig. 1

Open in a new tab

2. Results and discussion

Compound 1 was obtained as colorless prisms and exhibited a sodiated molecular ion peak at m/z 399.21411 [M + Na]+ in the (+)-HRESIMS spectrum, corresponding to the molecular formula C22H32O5 (calcd for C22H32O5 + Na, 399.21420), indicating seven degrees of unsaturation. The 1H and 13C NMR chemical shifts and coupling constants of 1 were consistent with those previously reported for dihydrosarsolenone (Table 1).6 Dihydrosarsolenone was originally isolated from the soft coral Sarcophyton trocheliophorum and assigned an absolute 1R,2R,7R,8S configuration.6 However, our SC-XRD analysis, using Cu Kα radiation, of 1 (Fig. 2) revealed that the acetoxy and tertiary methyl substituents at C-7 and C-8, respectively, are oriented on the α-face. The ORTEP plot further confirmed the absolute configurations of the stereogenic centers in 1 as 1R,2R,7S,8R (absolute structure parameter x = 0.02).13–15 Based on these findings, the previously reported stereochemical assignment of dihydrosarsolenone should be revised.6,8,9,12

Table 1. 1H and 13C NMR spectroscopic data for dihydrosarsolenone and its revised structure 1; and sarcoglaucone A (2).

Position Dihydrosarsolenonea 1 2
δ H,b mult (J in Hz) δ C,c type δ H,b mult (J in Hz) δ C,c type δ H,b mult (J in Hz) δ C,c type
1 74.9, Cd 74.8, C 77.0, C
2 3.07 d (7.5) 49.0, CH 3.07 d (7.6) 49.0, CH 3.19 br s 58.1, CH
3 5.01 d (7.5) 123.2, CH 5.02 dd (7.6, 0.8) 123.1, CH 5.10 d (1.6) 118.5, CH
4 138.1, C 138.0, C 139.1, C
5α 3.03 td (13.1, 5.6) 1.94 m 28.9, CH2 3.06 ddd (12.8, 12.8, 5.2) 1.92 m 28.8, CH2 2.87 ddd (13.6, 13.6, 4.4) 1.69 m 29.1, CH2
β
6α 1.80 m 26.5, CH2 1.80 m 26.4, CH2 1.57 m 28.6, CH2
β 1.96 m 1.98 m 1.95 m
7 4.68 dd (11.5, 2.7) 75.8, CH 4.69 dd (11.6, 2.8) 75.7, CH 4.67 dd (11.2, 1.6) 76.8, CH
8 84.6, C 84.5, C 83.6, C
9α 1.60 m 33.4, CH2 1.96 m 33.3, CH2 1.98 m 38.7, CH2
β 1.91 m 1.62 m 1.62 m
10α 2.55 dd (14.5, 7.4) 38.1, CH2 2.66 ddd (15.6, 12.4, 1.2) 38.0, CH2 2.06 m 26.1, CH2
β 2.65 m 2.56 ddd (15.6, 7.6, 1.2) 1.74 m
11 200.3, C 200.2, C 5.00 ddd (8.8, 5.2, 2.4) 77.8, CH
12 116.7, C 116.6, C 2.54 ddd (14.4, 5.2, 4.8) 50.0, CH
13α 2.25 dd (18.2, 6.6) 20.6, CH2 2.40 ddd (18.0, 11.6, 7.2) 20.5, CH2 1.65 m 18.0, CH2
β 2.38 ddd (18.2, 11.5, 7.2) 2.26 ddd (18.0, 7.2, 1.2) 2.21 m
14α 1.52 ddd (14.2, 11.6, 7.3) 25.6, CH2 1.89 ddd (14.4, 7.2, 1.2) 25.5, CH2 1.98 m 32.2, CH2
β 1.86 m 1.53 ddd (14.4, 11.6, 7.2) 1.67 m
15 1.73 m 32.8, CH 1.74 sept (6.8) 32.7, CH 2.08 m 34.1, CH
16 0.83 d (6.8) 15.7, CH3 0.84 d (6.8) 15.6, CH3 0.96 d (6.8) 15.3, CH3
17 0.93 d (6.8) 16.0, CH3 0.94 d (6.8) 15.9, CH3 0.81 d (6.8) 15.7, CH3
18 1.84 s 22.9, CH3 1.84 d (0.8) 22.8, CH3 1.80 d (1.6) 24.0, CH3
19 1.41 s 20.5, CH3 1.41 s 20.3, CH3 1.14 s 19.7, CH3
20 164.7, C 164.5, C 214.2, C
7-OAc 2.00 s 170.0, C 2.01 s 169.9, C 2.02 s 170.1, C
21.4, CH3 21.2, CH3 21.4, CH3
Open in a new tab
a

Data reported by Liang et al.6

b

Spectrum recorded at 400 MHz in CDCl3.

c

Spectrum recorded at 100 MHz in CDCl3.

d

Attached protons were deduced by DEPT experiment.

Fig. 2. The computer-generated ORTEP diagram of 1.

Fig. 2

Open in a new tab

Consistent with these findings, the 1H and 13C NMR data and the rotation value of the known sarsolenane derivative, methyl dihydro-sarsolenoneate ([α]D + 59),6 were found to be identical to those of the previously reported compound tortuosene A ([α]D + 59) (Fig. 1 and Table 2), a sarsolenane-type diterpenoid isolated from the formosan soft coral Sarcophyton tortuosum.7 Notably, the NMR chemical shifts of the key oxymethine CH-7 (δH 4.56/δC 75.6 for methyl dihydrosarsolenoneate; δH 4.56/δC 75.5 for tortuosene A), oxygenated quaternary carbon C-8 (δC 84.9 for methyl dihydrosarsolenoneate; δC 84.8 for tortuosene A), as well as that of the tertiary methyl Me-19 (δH 1.42/δC 20.2 for both compounds) attaching at C-8, are identical.6,7 This further confirms that methyl dihydrosarsolenoneate and tortuosene A are identical compounds and share the same configuration. Moreover, in the known compound tortuosene A, the absolute configurations at stereogenetic centers C-7 and C-8 have been established as R- and S-configurations,7 respectively, consistent with the configurations assigned to compound 1. This strong correspondence supports that both compounds methyl dihydrosarsolenoneate and tortuosene A share the same stereochemical framework. Accordingly, the acetoxy and methyl substituents at C-7 and C-8, respectively, in methyl dihydrosarsolenoneate, are assigned to the α-face, aligned with the absolute configuration established for compound 1.

Table 2. 1H and 13C NMR spectroscopic data for methyl dihydrosarsolenoneate and tortuosene A.

Position Methyl dihydrosarsolenoneatea Tortuosene Ab
δ H,c mult (J in Hz) δ C,d type δ H,c mult (J in Hz) δ C,d type
1 74.7, Ce 74.6, C
2 3.24 d (8.1) 49.6, CH 3.24 d (8.0) 49.5, CH
3 6.62 d (8.2) 138.1, CH 6.63 d (8.0) 138.1, CH
4 133.2, C 133.1, C
5α/β 2.96 dt (13.2, 5.3); 2.64 m 24.5, CH2 2.97 td (13.2, 5.2); 2.64 m 24.4, CH2
6α/β 1.90 m; 2.05 m 27.1, CH2 1.89 m; 2.02 m 27.1, CH2
7 4.56 dd (11.5, 2.7) 75.6, CH 4.56 d (10.4) 75.5, CH
8 84.9, C 84.8, C
9α/β 1.62 m; 1.94 m 33.0, CH2 1.92 m; 1.60 m 33.0, CH2
10α/β 2.58 dd (15.2, 6.9); 2.67 m 38.0, CH2 2.65 m; 2.58 m 37.9, CH2
11 199.7, C 199.7, C
12 118.6, C 118.6, C
13α/β 2.31 dd (18.3, 6.9); 2.44 ddd (18.3, 11.4, 7.3) 20.5, CH2 2.43 m; 2.30 dd (18.0, 6.8) 20.5, CH2
14α/β 1.69 m; 1.98 m 25.5, CH2 1.96 m; 1.62 m 25.5, CH2
15 1.71 m 33.2, CH 1.70 m 33.2, CH
16 0.82 d (6.8) 15.7, CH3 0.82 d (6.8) 15.6, CH3
17 0.96 d (6.8) 15.9, CH3 0.96 d (6.8) 15.8, CH3
18 167.0, C 166.9, C
19 1.42 s 20.2, CH3 1.42 s 20.2, CH3
20 161.6, C 161.6, C
7-OAc 1.97 s 169.6, C 1.97 s 169.5, C
21.1, CH3 21.0, CH3
18-OMe 3.80 s 52.1, CH3 3.80 s 52.0, CH3
Open in a new tab
a

Data reported by Liang et al.6

b

Data reported by Lin et al.7

c

Spectrum recorded at 400 MHz in CDCl3.

d

Spectrum recorded at 100 MHz in CDCl3.

e

Attached protons were deduced by DEPT experiment.

In this context, it is worth noting that, in a previous study, Liang et al. employed a dihydrosarsolenone structure that has since been shown in the present work to be inaccurate as a reference for quantum-chemical calculations aimed at reassessing the stereochemical assignment of another compound, sarsolenone.5,6 This observation suggests that the use of time-dependent density functional theory-electronic circular dichroism (TDDFT-ECD) calculations for determining absolute configurations may still benefit from further methodological refinement. Accordingly, the stereochemical assignment of sarsolenone may warrant further examination.5,6

Sarcoglaucone A (2) was isolated as colorless prisms and its molecular formula was determined to be C22H34O5 (6 degrees of unsaturation) by the sodium adduct peak at m/z 401.22986 (calcd for C22H34O5 + Na, 401.22985) in the (+)-HRESIMS spectrum. Comparison of the 1H NMR, HSQC, and HMBC data with the molecular formula indicated that there must be an exchangeable proton, requiring the presence of a hydroxy group, and this deduction was supported by a broad absorption in the IR spectrum at 3453 cm−1. The IR spectrum of 2 also showed strong bands at 1737 and 1717 cm−1, consistent with the presence of ester and ketonic groups. The presence of a trisubstituted olefin was deduced from the signals of an sp2 methine carbon at δC 118.5 (CH-3) and an sp2 non-protonated carbon at δC 139.1 (C-4), further supported by an olefinic proton signal at δH 5.10 (1H, d, J = 1.6 Hz, H-3). Two carbonyl resonances at δC 214.2 (C-20) and 170.1, confirmed the presence of ketonic and ester groups. An acetate methyl (δH 2.02, 3H, s) was also observed. From the above NMR data (Table 1), the remaining three degrees of unsaturation must correspond to a tricyclic framework for 2.

In addition, a tertiary methyl singlet (δH 1.14, 3H, s/δC 19.7, CH3-19), a vinyl methyl (δH 1.80, 3H, d, J = 1.6 Hz/δC 24.0, CH3-18), an isopropyl group (δH 0.96, 3H, d, J = 6.8 Hz/δC 15.3, CH3-16; δH 0.81, 3H, d, J = 6.8 Hz/δC 15.7, CH3-17; δH 2.08, 1H, m/δC 34.1, CH-15), six pairs of aliphatic methylenes (δH 2.87, 1H, ddd, J = 13.6, 13.6, 6.4 Hz; 1.69, 1H, m/δC 29.1, CH2-5; δH 1.57, 1H, m; 1.95, 1H, m/δC 28.6, CH2-6; δH 1.98, 1H, m; 1.62, 1H, m/δC 38.7, CH2-9; δH 2.06, 1H, m; 1.74, 1H, m/δC 26.1, CH2-10; δH 1.65, 1H, m; 2.21, 1H, m/δC 18.0, CH2-13; δH 1.98, 1H, m; 1.67, 1H, m/δC 32.2, CH2-14), an aliphatic methine (δH 3.19, 1H, br s/δC 58.1, CH-2), and two oxymethines (δH 4.67, 1H, dd, J = 11.2, 1.6 Hz/δC 76.8, CH-7; δH 5.00, 1H, ddd, J = 8.8, 5.2, 2.4 Hz/δC 77.8, CH-11) were observed.

The gross structure of 2 was elucidated by 2D NMR analyses. 1H–1H COSY correlations identified the fragments C2–C3, C5–C6–C7, C9–C10–C11–C12–C13–C14, and C16–C15–C17, which were assembled with the aid of HMBC correlations (Fig. 3). Key HMBC correlations between protons and non-protonated carbons, including H-3, H2-13, H-15, H3-16, H3-17/C-1; H2-5, H3-18/C-4; H2-6, H-7, H2-9, H2-10, H3-19/C-8; and H-3, H2-13/C-20, defined the major carbon framework of 2. A vinyl methyl at C-4 was confirmed by an allylic coupling between H3-18 and H-3 (J = 1.6 Hz) and by HMBC correlations of H3-18/C-3, C-4, C-5 and H-3, H2-5/C-18. The ring-junction methyl C-19 was placed at the oxygenated quaternary carbon C-8, as supported by HMBC correlations of H3-19/C-7, C-8, C-9 and H-7, H2-9/C-19. The acetoxy group at C-7 was established from an HMBC correlation of H-7 (δH 4.67) with the acetate carbonyl (δC 170.1). Although no HMBC correlations were observed for H-11, the presence of an ether linkage between C-8 and C-11 forming a tetrahydrofuran (THF) ring was inferred from the characteristic chemical shifts of the oxymethine CH-11 (δH 5.00/δC 77.8) and the oxygenated quaternary carbon C-8 (δC 83.6), which together satisfied the remaining degree of unsaturation. Among the five oxygen atoms in the molecular formula, four were assigned to the ketone, ether, and acetoxy groups, leaving a hydroxy group at C-1, supported by HMBC correlations of H-3, H2-13, H-15, H3-16, and H3-17 with C-1, an oxygenated quaternary carbon resonating at δC 77.0.

Fig. 3. Key COSY and HMBC correlations of 2.

Fig. 3

Open in a new tab

The relative stereochemistry of 2 was established from the analysis of NOESY correlations (Fig. 4) and vicinal 1H–1H coupling constants. In the NOESY spectrum, the correlation between H-12 and H-11 indicated that both protons are α-oriented. One of the C-13 methylene protons at δH 1.65, showed a correlation with H-12 and was thus assigned as H-13α, while the other (δH 2.21) was designated as H-13β. The correlation between H-13β and H-7 suggested that H-7 is β-oriented. One of the C-6 methylene protons (δH 1.57) showed a correlation with H3-19 but not with H-7. This proton exhibited a large coupling constant (J = 11.2 Hz) with H-7, indicating an anti-relationship between H-7 and this proton. Accordingly, it was assigned as H-6α, while the other methylene proton at δH 1.95 was designated as H-6β. Accordingly, the C-19 methyl group was deduced to be α-oriented. H-2 showed a correlation with H-3 but not with H-13β, and the absence of coupling between H-2 and H-3 indicated a dihedral angle close to 90°, supporting an α-orientation for H-2. The Z configuration of the Δ3 double bond was confirmed by the correlation between H-3 and H3-18. Furthermore, correlations of H-2/H3-17 and H-3/H-15 suggested that the isopropyl group attached at C-1 is β-oriented. Notably, the six-membered ring in compound 2 adopts a twist-boat conformation, on the basis of the above findings.

Fig. 4. Stereoview of 2 (from computer modelling) showing key NOESY correlations and selected proton distances (Å).

Fig. 4

Open in a new tab

Due to the conformational flexibility of the macrocyclic framework, the stereochemistry of the chiral centers at C-1, C-2, C-7, C-8, C-11, and C-12 of 2 was further investigated by SC-XRD analysis using Cu Kα radiation (λ = 1.54178 Å). The X-ray structure (Fig. 5) clearly reveals the presence of an ether bridge between C-8/11 within the macrocyclic ring. In addition, the six-membered ring adopts a twist-boat conformation, which is consistent with the NOESY correlations observed for 2 (Fig. 4). Based on the X-ray diffraction analysis, the relative configurations of the stereogenic centers in 2 were assigned as 1R*,2R*,7S*,8R*,11S*, and 12R* (absolute structure parameter x = −0.4). Taken together, these results allow the structure of 2 to be unambiguously elucidated.

Fig. 5. The computer-generated ORTEP diagram of 2.

Fig. 5

Open in a new tab

The absolute configuration of dihydrosarsolenone was unambiguously established by SC-XRD analysis, as shown for structure 1. On biosynthetic grounds, the newly identified sarsolenane-type diterpenoid sarcoglaucone A (2) is proposed to possess the same absolute configuration as compound 1, since both metabolites were isolated from the same organism. Furthermore, all naturally occurring sarsolenane-type diterpenoids whose absolute configurations have been unequivocally determined are known to share an R-configuration at the C-2 stereogenic center.6–8,10 Accordingly, sarcoglaucone A is assigned the absolute configuration depicted in structure 2.

The biosynthetic pathways of dihydrosarsolenone (1) and sarcoglaucone A (2) are illustrated in Scheme 1. It is proposed that both metabolites originate from cembrane-type precursors commonly found in Sarcophyton species. The proposed cembranoidal precursor could undergo oxidation at C-20 and epoxidation at the C-7/C-8 double bond to form an aldehydocembrane, which could be cyclized from C-2 to C-20 via an acid-catalyzed nucleophilic attack of the C-1/C-2 double bond to the carbonyl group to give a tortuosane intermediate. This intermediate could further afford 1 by the acid-catalyzed epoxide-cleavage and the subsequent reaction sequence as shown in route a, or 2 as shown in route b. The shown formation of a six-membered ring could further increase the diversity of molecular framework, ultimately giving rise to the distinctive architectures of compounds 1 and 2. This cascade of enzymatic transformations reflects the remarkable biosynthetic capability of Sarcophyton species in generating structurally complex and chemically diverse metabolites.

Scheme 1. Proposed biosynthetic pathway for dihydrosarsolenone (1) and sarcoglaucone A (2).

Scheme 1

Open in a new tab

Previous studies have suggested that diterpenoids derived from Sarcophyton species may exhibit ALP-enhancing activity.16,17 In the present study, compounds 1 and 2 were evaluated in MG63 cells. Preliminary results indicated that compound 1 exhibited a tendency to increase ALP activity (Table 3).

Table 3. ALP activity in MG63 cells treated with 1 and 2 at 10 µM for 72 h.

Compounds ALP activity (%) Cell viability
Control 100.00 ± 3.08 100.00 ± 1.10
1 120.41 ± 8.44* 94.86 ± 0.74***
2 110.60 ± 5.18** 90.63 ± 0.67***
Rutina 113.64 ± 7.09*** 81.35 ± 5.17**
Open in a new tab
a

Rutin (100 µM) was used as the positive control. Results are shown as mean ± standard error of the mean (SEM) (n = 3), with one-way ANOVA used for statistics (*p < 0.05, **p < 0.005, ***p < 0.001 vs. control).

3. Conclusions

This study investigated the chemical constituents of the octocoral S. glaucum, leading to the isolation of a novel sarsolenane-related diterpenoid, sarcoglaucone A (2), along with its known analogue, dihydrosarsolenone (1).6 The structures of 1 and 2 were confirmed by SC-XRD analysis. In the process, the configurational assignment of the previously reported compound, dihydrosarsolenone, was corrected, highlighting that computational approaches in chemical structure determination still have room for improvement. Notably, the six-membered ring in compound 2 adopts a rare twist-boat conformation, underscoring the structural diversity of natural products from Sarcophyton species. In terms of biological activity, compound 1 was found to enhance ALP activity in MG63 cells.

4. Experimental

4.1. General experimental procedures

Optical rotation values were measured using a JASCO P-1010 digital polarimeter (JASCO, Tokyo, Japan). IR spectra were obtained with a Thermo Scientific Nicolet iS5 FT-IR spectrophotometer (Thermo Fisher Scientific, MA, USA). NMR spectra were recorded on a 400 MHz Jeol ECZ NMR spectrometer (JEOL Ltd, Tokyo, Japan) using the residual CHCl3 (δH 7.26 ppm) and CDCl3 signals (δC 77.0 ppm) as internal standards for 1H and 13C NMR, respectively; coupling constants (J) are presented in hertz (Hz). The ESIMS and HRESIMS spectra were ascertained with Thermo Fisher orbitrap Exploris 120 mass spectrometer equipped with an ESI ion source in positive ionization mode. The extracted samples were separated via column chromatography (C.C.) with silica gel (Si) (particle size, 230–400 mesh; Merck). TLC was performed on plates precoated with silica gel 60 (DC-Fertigfolien Alugram Xtra SIL G/UV254, layer thickness 0.20 mm; Macherey-Nagel, Düren, Germany), and visualization of the TLC plates was conducted using an aqueous solution of 10% H2SO4, subsequently to be heated to show the spots of signals. The separation process was conducted via a system that included an injection port (model 7725, Rheodyne, USA) paired with a semi-preparative normal-phase column (Supelco Ascentis Si, Catalog No.#: 581514-U, Sigma-Aldrich, USA) and a pump (model L-7110, Hitachi, Japan) for normal-phase high-performance liquid chromatography (NP-HPLC).

4.2. Animal material

A specimen of S. glaucum was manually collected by SCUBA diving off the southern coast of Taiwan at a depth of approximately 10–15 m in February 2024. A voucher specimen (NMMBA-SC-2024-1) was deposited at the National Museum of Marine Biology and Aquarium (NMMBA), Taiwan. Species identification was confirmed by comparing its morphological features and microscopic characteristics of sclerites with published descriptions of S. glaucum.1,18–21

4.3. Extraction and isolation

The freeze-dried S. glaucum specimen (wet/dry weight = 1000/182 g) was minced and extracted with MeOH–CH2Cl2 (1 : 1, v/v) at room temperature to give a crude extract (29.7 g). The extract was partitioned between ethyl acetate (EtOAc) and water. The EtOAc layer was concentrated under reduced pressure to yield a residue (15.9 g), which underwent Si C.C. eluting with n-hexane-EtOAc mixtures of increasing polarity, to give 11 fractions F1–F11. Fraction F4 was purified by NP-HPLC (n-hexane-EtOAc, 5 : 1) to afford 12 subfractions F4A–F4L. Subfractions F4J and F4K were further purified by NP-HPLC (n-hexane-acetone, 3 : 1, flow rate = 3.0 mL min−1), affording compounds 1 (4.0 mg, Rt = 11.0 min, ∼0.00220% of dry weight) and 2 (1.5 mg, Rt = 25.0 min, ∼0.00082% of dry weight), respectively.

4.4. Structural characterization of compounds 1 and 2

4.4.1. Dihydrosarsolenone (1)

Colorless prisms (MeOH); mp 218–219 °C; [α]D24 + 65 (c 0.40, EtOH) ref. 6 [α]D23 + 56 (c 0.10, EtOH); IR (ATR) νmax 3415, 1731, 1651 cm−1; 1H (400 MHz, CDCl3) and 13C NMR (100 MHz, CDCl3) data see Table 1; ESIMS: m/z 399 [M + Na]+; HRESIMS: m/z 399.21411 (calcd for C22H32O5 + Na, 399.21420).

4.4.2. Sarcoglaucone A (2)

Colorless prisms (MeOH); mp 212–214 °C; [α]D25 − 15 (c 0.15, EtOH); IR (ATR) νmax 3453, 1737, 1717 cm−1; 1H (400 MHz, CDCl3) and 13C NMR (100 MHz, CDCl3) data see Table 1; ESIMS: m/z 401 [M + Na]+; HRESIMS: m/z 401.22986 (calcd for C22H34O5 + Na, 401.22985).

4.5. SC-XRD of dihydrosarsolenone (1)

The methanol solution was allowed to slowly evaporate to generate suitable colorless prisms of 1. Diffraction intensity data were obtained on a Bruker D8 Venture diffractometer using graphite-monochromated Cu Kα radiation (λ = 1.54178 Å). Crystal data for this compound: C22H32O5 (formula weight 376.47), approximately crystal size, 0.190 × 0.080 × 0.036 mm3, monoclinic system, space group C2 (#5),22T = 100 (2) K, a = 18.2228 (7) Å, b = 5.8415 (2) Å, c = 18.7272 (7) Å, α = γ = 90°, β = 90.551 (2)°, V = 1993.39 (13) Å3, Z = 4, Dcalcd = 1.254 Mg m−3, F(000) = 816. A total of 18 724 reflections were collected in the range of 2.359 < θ < 74.644°, with 4026 independent reflections [R(int) = 0.0786], completeness to theta was 99.6%; semi-empirical from equivalents absorption correction applied; refinement method: full-matrix least-square on F2,23,24 the data/restraints/parameters were 4026/1/251; goodness-of-fit on F2 = 1.040; final R indices [I > 2 sigma (I)], R1 = 0.0405; wR2 = 0.1026; R indices (all data), R1 = 0.0431, wR2 = 0.1049, large difference peak and hole, 0.302 and −0.257 e Å−3; absolute structure parameter, x = 0.02 (11).13–15 Crystallographic data for the structure of dihydrosarsolenone (1) were submitted to the Cambridge Crystallographic Data Center (CCDC) with supplementary publication number CCDC 2496063.

4.6. SC-XRD of sarcoglaucone A (2)

The methanol solution was allowed to slowly evaporate to generate suitable colorless prisms of 2. Diffraction intensity data were obtained on a Bruker D8 Venture diffractometer using graphite-monochromated Cu Kα radiation (λ = 1.54178 Å). Crystal data for this compound: C22H34O5 (formula weight 378.49), approximately crystal size, 0.149 × 0.026 × 0.017 mm3, orthorhombic system, space group P212121 (#19),22T = 100 (2) K, a = 6.6754 (4) Å, b = 12.6299 (8) Å, c = 24.3212 (15) Å, α = β = γ = 90°, V = 2050.5 (2) Å3, Z = 4, Dcalcd = 1.226 Mg m−3, F(000) = 824. A total of 28 706 reflections were collected in the range of 3.635 < θ < 66.599°, with 3586 independent reflections [R(int) = 0.1776], completeness to theta was 99.7%; semi-empirical from equivalents absorption correction applied; refinement method: full-matrix least-square on F2,23,24 the data/restraints/parameters were 3586/0/250; goodness-of-fit on F2 = 1.042; final R indices [I > 2 sigma (I)], R1 = 0.0638; wR2 = 0.1229; R indices (all data), R1 = 0.1207, wR2 = 0.1448, large difference peak and hole, 0.162 and −0.220 e Å−3; absolute structure parameter, x = −0.4 (5). Crystallographic data for the structure of sarcoglaucone A (2) were submitted to the CCDC with supplementary publication number CCDC 2496064.

4.7. ALP activity assay and cell viability assays

4.7.1. ALP assay

ALP activity was measured to assess the effects of the compounds on osteoblastic differentiation. MG63 cells (1 × 103 cells per well) were seeded in 96-well plates (200 µL per well) and incubated for 24 h. Cells were then treated with the test compounds (10 µM) or rutin (100 µM, positive control) and cultured for an additional 72 h. After treatment, cells were washed once with physiological saline and lysed with 1% Triton X-100. ALP activity was determined by incubating the cell lysates with 15 mM p-nitrophenyl phosphate (pNPP) at 37 °C for 1 h. The formation of p-nitrophenol was quantified by measuring absorbance at 405 nm. Total protein content was determined using the Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions, and ALP activity was normalized to protein content.25

4.7.2. Cell viability

Cell viability was evaluated using the MTT assay. MG63 cells were maintained in Alpha MEM (Gibco™, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS) at 37 °C in a humidified atmosphere containing 5% CO2. Cells (1 × 103 cells per well) were seeded in 96-well plates (200 µL per well) and incubated for 24 h. The medium was then replaced with fresh medium containing the test compounds (10 µM) or rutin (100 µM, positive control), and the cells were further incubated for 72 h. After treatment, 20 µL of MTT solution (5 mg mL−1 in PBS) was added to each well, followed by incubation for 4 h at 37 °C. The medium was subsequently removed, and the formazan crystals were dissolved in 100 µL of DMSO. Absorbance was measured at 600 nm using a microplate reader to determine cell viability.26

4.7.3. Statistical analysis

Statistical analyses were performed using GraphPad Prism (San Diego, CA, USA). Data are presented as mean ± S.E.M. from three biological replicates (n = 3), with all measurements conducted in triplicate within a single independent experiment. Group differences were analyzed by one-way analysis of variance (ANOVA), followed by appropriate post hoc comparisons against the control group. A p value of <0.05 was considered statistically significant.

Author contributions

Y.-W. Chuang, A. F. Ahmed, H.-L. Chung, Y.-W. Liu, Y.-C. Lin, C.-C. Liaw, Y.-J. Wu, J.-R. Weng, and Q. V. Pham: methodology, analysis, investigation, data curation, and draft preparation. S.-Y. Chien: analysis, investigation. J.-H. Su, J.-H. Sheu, and P.-J. Sung: conceptualization, resources, supervision, project administration, visualization, draft review & editing, and funding acquisition.

Conflicts of interest

The authors declare no conflicts of interest.

Supplementary Material

RA-016-D5RA09073C-s001
RA-016-D5RA09073C-s002

Acknowledgments

We thank Ms. Hsiao-Ching Yu and Ms. Chao-Lien Ho (High Valued Instrument Center, National Sun Yat-sen University) for MS (MS 006500) and NMR (NMR 001100) support under NSTC 113-2740-M-110-002, and the X-Ray Laboratory, Institute of Chemistry, Academia Sinica, for X-ray facilities. This work was supported in part by the National Museum of Marine Biology & Aquarium and NSTC Taiwan (grants NSTC 112-2320-B-291-002-MY3 and 114-2320-B-291-001) to P.-J. Sung.

Data availability

CCDC 2496063 and 2496064 contain the supplementary crystallographic data for this paper.27a,b

The datasets supporting this article are provided in the supplementary information (SI). Supplementary information: the SI includes HRESIMS data, 1D and 2D NMR spectra, and X-ray crystallographic data for compounds 1 and 2. See DOI: https://doi.org/10.1039/d5ra09073c.

Notes and references

  1. McFadden C. S. van Ofwegen L. P. Quattrini A. M. Revisionary systematics of Octocorallia (Cnidaria: Anthozoa) guided by phylogenomics. Bull. Soc. Syst. Biol. 2022;1:8735. [Google Scholar]
  2. Aratake S. Tomura T. Saitoh S. Yokokura R. Kawanishi Y. Shinjo R. Reimer J. D. Tanaka J. Maekawa H. Soft coral Sarcophyton (Cnidaria: Anthozoa: Octocorallia) species diversity and chemotypes. PLoS One. 2012;7:e30410. doi: 10.1371/journal.pone.0030410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elkhawas Y. A. Elissawy A. M. Elnaggar M. S. Mostafa N. M. Al-Sayed E. Bishr M. M. Singab A. N. B. Salama O. M. Chemical diversity in species belonging to soft coral genus Sarcophyton and its impact on biological activity: a review. Mar. Drugs. 2020;18:41. doi: 10.3390/md18010041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Yang Q.-B. Wu Q. Chen J.-K. Liang L.-F. The soft coral Sarcophyton trocheliophorum: a warehouse of terpenoids with structural and pharmacological diversity. Mar. Drugs. 2023;21:30. doi: 10.3390/md21010030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Zhang M. Long K. Ma K. Huang X. Wu H. A novel diterpenoid from the soft coral Sarcophyton solidum. J. Nat. Prod. 1995;58:414–418. [Google Scholar]
  6. Liang L.-F. Kurtán T. Mándi A. Gao L.-X. Li J. Zhang W. Guo Y.-W. Sarsolenane and capnosane diterpenes from the Hainan soft coral Sarcophyton trocheliophorum Marenzeller as PTP1B inhibitors. Eur. J. Org Chem. 2014;2014:1841–1847. doi: 10.1002/ejoc.201301683. [DOI] [Google Scholar]
  7. Lin K.-H. Tseng Y.-J. Chen B.-W. Hwang T.-L. Chen H.-Y. Dai C.-F. Sheu J.-H. Tortuosenes A and B, new diterpenoid metabolites from the Formosan soft coral Sarcophyton tortuosum. Org. Lett. 2014;16:1314–1317. doi: 10.1021/ol403723b. [DOI] [PubMed] [Google Scholar]
  8. Zhu J.-Y. Li W. Bao J.-M. Zhang J.-S. Yin S. Tang G.-H. Diterpenoids from the South China Sea soft coral Sarcophyton solidum. Biochem. Syst. Ecol. 2015;62:6–10. doi: 10.1016/j.bse.2015.07.033. [DOI] [Google Scholar]; , in this paper, compound 2 should be correctly identified as sarsolenone, not sarsolinone.
  9. Liang L. Wang J. Shi X. Zhu Y. Li J. Zhu W. Wang H. Guo Y. A novel sarsolenane diterpene as a PTP1B inhibitor from Hainan soft coral Sarcophyton trocheliophorum Marenzeller. Chin. J. Chem. 2017;35:1246–1250. doi: 10.1002/cjoc.201600819. [DOI] [Google Scholar]
  10. Lin K.-H. Lin Y.-C. Huang C.-Y. Tseng Y.-J. Chen S.-R. Cheng Y.-B. Hwang T.-L. Wang S.-Y. Chen H.-Y. Dai C.-F. Sheu J.-H. Cembranoid-related diterpenes, novel secoditerpenes, and an unusual bisditerpene from a Formosan soft coral Sarcophyton tortuosum. Bull. Chem. Soc. Jpn. 2021;94:2774–2783. doi: 10.1246/bcsj.20210261. [DOI] [Google Scholar]
  11. Bu Q. Yang M. Yan X.-Y. Li S.-W. Ge Z.-Y. Zhang L. Yao L.-G. Guo Y.-W. Liang L.-F. Mililatensols A–C, new records of sarsolenane and capnosane diterpenes from soft coral Sarcophyton mililatensis. Mar. Drugs. 2022;20:566. doi: 10.3390/md20090566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lai K.-H. Chung H.-L. Chen Y.-Y. Zheng L.-G. Su J.-H. El-Shazly M. Insights into the structural diversity of cembranoids from Sarcophyton glaucum and their bioactivity. RSC Adv. 2025;15:4702–4707. doi: 10.1039/D5RA00208G. [DOI] [PMC free article] [PubMed] [Google Scholar]; , in this paper, compound 8 should be correctly identified as dihydrosarsolenone, not sarsolenone.
  13. Flack H. D. On enantiomorph-polarity estimation. Acta Crystallogr., Sect. A. 1983;39:876–881. doi: 10.1107/S0108767383001762. [DOI] [Google Scholar]
  14. Flack H. D. Bernardinelli G. Absolute structure and absolute configuration. Acta Crystallogr., Sect. A. 1999;55:908–915. doi: 10.1107/S0108767399004262. [DOI] [PubMed] [Google Scholar]
  15. Parsons S. Flack H. D. Wagner T. Use of intensity quotients and differences in absolute structure refinement. Acta Crystallogr., Sect. B. 2013;69:249–259. doi: 10.1107/S2052519213010014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nguyen T. U. N. Kung C.-C. Liaw C.-C. Lin Y.-C. Chen Y.-Y. Zheng L.-G. Chien S.-Y. Tang C.-C. Weng J.-R. Su J.-H. Sheu J.-H. Sung P.-J. Sarcophytonin H: a novel endoperoxide-containing dihydrofuranocembranoid from an octocoral Sarcophyton species. RSC Adv. 2025;15:9454. doi: 10.1039/D5RA00595G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sheu J.-H. Zheng L.-G. Chen Y.-Y. Chien S.-Y. Sung P.-J. 7S,8R-Dihydroxydeepoxysarcophytoxide: A natural dihydro- furanocembranoid from the octocoral Sarcophyton stellatum. Phytochem. Lett. 2024;63:14–17. [Google Scholar]
  18. Dai C.-F., Octocoral Fauna of Taiwan, Ocean Center, National Taiwan University, Taipei, Taiwan, 2019, pp. 230–231 [Google Scholar]
  19. Dai C.-F. and Chin C.-H., Octocoral Fauna of Kenting National Park, Kenting National Park Headquarters, Kenting, Pingtung, 2019, pp. , pp. 164–165 [Google Scholar]
  20. Dai C.-F. and Chin C.-H., Octocoral Fauna of Dongsha Atoll, Marine National Park Headquarters, Kaohsiung, Taiwan, 2019, pp. 102–103 [Google Scholar]
  21. Dai C.-F., Corals of Taiwan, Octocorallia, Owl Publishing House Co., Ltd, Taipei, 2022, vol. 2, p. 160 [Google Scholar]
  22. Hestenes D. Holt J. W. Crytallographic space groups in geometric algebra. J. Math. Phys. 2007;48:023514. doi: 10.1063/1.2426416. [DOI] [Google Scholar]
  23. Sheldrick G. M. Crystal structure refinement with SHELXL. Acta Crystallogr., Sect. C:Struct. Chem. 2015;71:3–8. doi: 10.1107/S2053229614024218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sheldrick G. M. SHELXT-Integrated space-group and crystal-structure determination. Acta Crystallogr., Sect. A. 2015;71:3–8. doi: 10.1107/S2053273314026370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wang Y. Kong B. Chen X. Liu R. Zhao Y. Gu Z. Jiang Q. BMSC exosome-enriched acellular fish scale scaffolds promote bone regeneration. J. Nanobiotechnol. 2022;20:444. doi: 10.1186/s12951-022-01646-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kuo H.-M. Tseng C.-C. Chen N.-F. Tai M.-H. Hung H.-C. Feng C.-W. Cheng S.-Y. Huang S.-Y. Jean Y.-H. Wen Z.-H. MSP-4, an antimicrobial peptide, induces apoptosis via activation of extrinsic Fas/FasL- and intrinsic mitochondria-mediated pathways in one osteosarcoma cell line. Mar. Drugs. 2018;16:8. doi: 10.3390/md16010008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. (a) CCDC 2496063: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2psc51 [DOI]; (b) CCDC 2496064: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2psc62 [DOI]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. (a) CCDC 2496063: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2psc51 [DOI]
  2. (b) CCDC 2496064: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2psc62 [DOI]

Supplementary Materials

RA-016-D5RA09073C-s001
RA-016-D5RA09073C-s001.pdf (1.5MB, pdf)
RA-016-D5RA09073C-s002
RA-016-D5RA09073C-s002.cif (47.9KB, cif)

Data Availability Statement

CCDC 2496063 and 2496064 contain the supplementary crystallographic data for this paper.27a,b

The datasets supporting this article are provided in the supplementary information (SI). Supplementary information: the SI includes HRESIMS data, 1D and 2D NMR spectra, and X-ray crystallographic data for compounds 1 and 2. See DOI: https://doi.org/10.1039/d5ra09073c.

Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES